Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $76.39 ($482K) on 2016-12-21, disclosed to the SEC on 2016-12-22.
Scheduled sale ($482k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.65 | 4,100 | $302K | 62.6% |
| 2 | $74.35 | 1,300 | $97K | 20.1% |
| 3 | $75.61 | 800 | $60K | 12.5% |
| 4 | $76.39 | 300 | $23K | 4.8% |
| Total | $74.16 avg | 6,500 | $482K | 100% |
| Filing → |
| VRTX | SELL | 2017-01-06 | $501K | — | Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-16 | $504K | — | Filing → |